CHPA Applauds OMUFA Introduction, Calls for Inclusion of GRASE and Sunscreen Reforms

Industry calls for clear GRASE standards and broader adoption of non-animal testing to advance innovation and safety across all topical OTC products.
Share page:

(WASHINGTON, D.C.) – The Consumer Healthcare Products Association (CHPA) released the below statement today applauding U.S. Representatives Bob Latta (R-OH), Diana DeGette (D-CO), Dan Crenshaw (R-TX) and Debbie Dingell (D-MI) for introducing bipartisan legislation to reauthorize the Over-the-Counter Monograph User Fee Act (OMUFA). This critical legislation will continue to build on the modernization of the OTC monograph system and ensure the U.S. Food and Drug Administration (FDA) has the resources to support a timely, science-based review of OTC medicines.   

 

“CHPA applauds Representatives Latta, DeGette, Crenshaw and Dingell for their leadership in introducing this important reauthorization and for their continued support of self-care,” said CHPA President & CEO Scott Melville. “As the industry works to deliver safe, effective, and innovative OTC products to consumers, we look forward to working with Congress on refinements to the bill to ensure the final legislation maximizes the potential of monograph reform and can continue to provide savings and innovation to consumers. That includes inserting provisions into OMUFA to clarify how FDA evaluates the Generally Recognized as Safe and Effective (GRASE) standard, creating a clearer path for early agreement on data needs, and improving the efficiency of making product improvements while maintaining strong safety standards.

 

“We also believe this reauthorization legislation provides a much-needed opportunity to modernize the sunscreen review process so Americans can access the most advanced, effective sun protection options used safely around the world. As part of that effort, CHPA strongly supports the use of scientifically advanced, non-animal testing methods—not just for sunscreen ingredients, but for all topical products—to help ensure safety while giving consumers innovative, new consumer healthcare products. Ultimately, we hope the committee will include these common-sense improvements as they will allow consumers to continue benefiting from timely access to the latest advancements in self-care.” 

The Consumer Healthcare Products Association (CHPA), founded in 1881, is the national trade association representing the leading manufacturers and marketers of consumer healthcare products, including over-the-counter (OTC) medicines, dietary supplements, and OTC medical devices. CHPA is committed to empowering self-care by ensuring that Americans have access to products they can count on to be reliable, affordable, and convenient, while also delivering new and better ways to get and stay healthy. Visit www.chpa.org.

Issues: